Beijing Biostar Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	38.09	38.09	60.11	268.42	224.45	3.78
Short-Term Investments	302.32	302.32	224.17	-	-	-
Trading Asset Securities	235.61	235.61	444.99	536.96	654.07	221.13
Cash & Short-Term Investments	576.02	576.02	729.26	805.37	878.52	224.91
Cash Growth	156.11%	-21.01%	-9.45%	-8.33%	290.61%	-
Accounts Receivable	11.16	11.16	34.62	25.12	-	0.23
Other Receivables	4.79	4.79	4.33	0.57	0.05	9.9
Receivables	15.95	15.95	38.95	25.81	0.36	10.23
Inventory	27.27	27.27	31.11	22.67	5.75	2.57
Other Current Assets	14.3	14.3	5.35	12.45	17.55	0.85
Total Current Assets	633.53	633.53	804.67	866.3	902.18	238.56
Property, Plant & Equipment	136.19	136.19	117.76	79.47	78.35	81.71
Other Intangible Assets	1.63	1.63	2.83	16.31	14.05	14.29
Other Long-Term Assets	1	1	1.07	1.99	1	13.8
Total Assets	772.34	772.34	926.34	964.06	995.58	348.36
Accounts Payable	24.44	24.44	20.1	4.28	2.48	5.46
Accrued Expenses	10.75	10.75	11.89	10	5.87	6.31
Current Portion of Leases	0.73	0.73	1.09	0.67	-	-
Current Income Taxes Payable	-	-	-	0	-	-
Current Unearned Revenue	-	-	-	1	1	1
Other Current Liabilities	7.83	7.83	18.64	2.21	2.35	5.73
Total Current Liabilities	43.74	43.74	51.73	18.16	11.7	18.5
Long-Term Leases	0.17	0.17	0.81	0.48	-	-
Long-Term Unearned Revenue	0.82	0.82	1.53	1.56	2.86	3.93
Other Long-Term Liabilities	4.45	4.45	4.35	-	-	-
Total Liabilities	49.18	49.18	58.41	20.2	14.56	22.43
Common Stock	350	350	350	350	34.99	26.69
Additional Paid-In Capital	-	-	-	972.05	1,200	487.62
Retained Earnings	-	-	-	-378.19	-253.63	-188.38
Comprehensive Income & Other	373.16	373.16	517.93	-	-	-
Shareholders' Equity	723.16	723.16	867.93	943.87	981.02	325.92
Total Liabilities & Equity	772.34	772.34	926.34	964.06	995.58	348.36
Total Debt	0.9	0.9	1.9	1.14	-	-
Net Cash (Debt)	575.12	575.12	727.36	804.23	878.52	224.91
Net Cash Growth	155.71%	-20.93%	-9.56%	-8.46%	290.61%	-
Net Cash Per Share	1.64	1.64	2.08	2.30	-	-
Filing Date Shares Outstanding	364.59	364.59	350	350	-	-
Total Common Shares Outstanding	350	350	350	350	-	-
Working Capital	589.79	589.79	752.95	848.14	890.48	220.06
Book Value Per Share	2.07	2.07	2.48	2.70	-	-
Tangible Book Value	721.53	721.53	865.09	927.56	966.97	311.63
Tangible Book Value Per Share	2.06	2.06	2.47	2.65	-	-
Buildings	72.76	72.76	72.69	67.93	59.9	59.9
Machinery	42.86	42.86	41.47	38.55	36.57	34.99
Construction In Progress	53.37	53.37	26.99	2.05	4.91	3.16

Source: S&P Capital IQ. Standard template. Financial Sources.